ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2024 Earnings Call Transcript December 14, 2023 ImmunoPrecise Antibodies Ltd. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.09. Operator: Good morning, ladies and gentlemen. Thank you for joining us today for IPA’s Earnings Call covering the Second Quarter of Fiscal Year 2024. I am Sarah and I have […]
ImmunoPrecise Antibodies Ltd. , a leader in AI-driven biotherapeutic research and technology, is pleased to announce important Board of Director changes and upcoming financial reporting.
ImmunoPrecise Antibodies (IPA) Announces Key Board and Board Committee Chair Appointments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.